Dose dependent, new onset QTc prolongation in a patient with paranoid schizophrenia receiving Clozapine

Asian Journal of Psychiatry

Volumn 4, Issue 3, 2011, Pages 221-222

  Sharma, Taral R ^a   Chahil, Ritu ^b  

^a VIRGINIA TECH CARILION SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; HALOPERIDOL;

ADULT; CASE REPORT; DOSE RESPONSE; ELECTROCARDIOGRAM; HUMAN; INCIDENTAL FINDING; LETTER; MALE; MENTAL PATIENT; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; QT PROLONGATION; SYMPTOM; TREATMENT RESPONSE;

EID: 80052965907     PISSN: 18762018     EISSN: 18762026     Source Type: Journal    
DOI: 10.1016/j.ajp.2011.06.005     Document Type: Letter

References (4)

1. Agelink M., Majewski T., Wurthmann C., Lukas K., Ullrich H., Linka T., Klieser E. Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole and clozapine. J. Clin. Psychopharmacol. 2001, 21:8-13.
2. Benoit S., Mendelsohn A., Nourjah P., Staffa J., Graham D. Risk factors for prolonged QTc among US adults: third National Health and Nutrition Examination Survey. Eur. J. Cardiovasc. Prev. Rehabil. 2005, 12(4):363-368.
3. Sauer A., Moss A., McNitt S., Peterson D., Zareba W., Robinson J., Qi M., Goldenberg I., Hobbs J.B., Ackerman M., Benhorin J., Hall W., Kaufman E., Locati E., Napolitano C., Priori S., Schwartz P., Towbin J., Vincent G., Zhang L. Long QT syndrome in adults. J. Am. Coll. Cardiol. 2007, 49(3):329-337.
4. Kang U., Kwon J., Ahn Y., Chung S., Ha J., Koo Y., Kim Y. Electro-cardiographic abnormalities in patients treated with clozapine. J. Clin. Psychiatry 2000, 61(6):441-446.